P2RX7 and cancer: Moreover, by genome-wide analysis, Pan and colleagues identified P2X7-V3 as a potent enhancer of the PI3K/AKT pathway that is, again, well known to be activated downstream P2X7 receptor in cancer [72,77,94,95].